← Eichor
Study identifier: NCT04777825 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Heart Rate Variability Biofeedback Training in Psychogenic Disorders

Condition: Psychogenic Dystonia  ·  Sponsor: University Hospital, Montpellier

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

To study whether Heart Rate Variability (HRV) biofeedback training can improve abnormal head posture and painful symptomatology in patients with "cervical dystonia" not selected for DBS after extensive screening in a specialized unit but diagnosed " dysfunctional ". Patients of the respiratory coherence group will receive HRV biofeedback training for 12 sessions during a 6 months-period. The hypothesis is that this kind of physiological noninvasive therapy increasing coherence respiratory, will reduce pain and patient's complain about their psychogenic abnormal head posture. Improvement of anxiety, depression and quality of life are expected.

This description comes directly from the study's public registry record.

Talk to the study team

Emily SANREY, MSc  ·  467337445  ·  e-sanrey@chu-montpellier.fr

Valérie GIL, CTA  ·  467337464  ·  v-gil@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Montpellier University HospitalMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04777825